GlobeNewswire by notified

Orion’s Clinical Trial Shows Significant Improvement for Chronic Pain Patients Using Virtual Reality Therapy

Share

ORION CORPORATION PRESS RELEASE 9 JUNE 2021 at 12.00 noon EEST

Orion’s Clinical Trial Shows Significant Improvement for Chronic Pain Patients Using Virtual Reality Therapy

A novel treatment, a digital therapeutics software solution for Chronic Pain (DTxP), has shown statistically significant benefit over passive (placebo)control and standard care interventions for fear of movement, patient clinical global impression of change (PGIC) and quality of life in adult patients with chronic low back pain (CLBP). Results from Orion Corporation’s pilot study ‘VIRPI were announced at the IASP 2021 Virtual World Congress On Pain.

Results from the ‘VIRPI’ study in patients with CLBP showed that TSK score (Tampa Scale for Kinesiophobia assessing fear of movement) was significantly reduced at the end-of-intervention (EOI) for DTxP. Primary analysis for the difference between DTxP and passive control at EOI was statistically significant: -4.7 points (-9.4 to -0.1, p=0.046) and increased when compared to standard care -6.1 (-10.9 to -1.3, p=0.014). Patient clinical global impression of change (PGIC), which reflects a patient's belief about the efficacy of the treatment, and their quality of life (QoL) also reached a statistically significant difference at EOI in comparison to passive control and standard care groups.

Non-statistically significant improvements were reported with DTxP for Oswestry Disability Index (ODI), pain interference (Patient-Reported Outcomes Information System: PROMIS), and pain intensity (PROMIS-Numerical Rating Scale). Adverse effects appeared acceptable and similar to passive control.

“There is an unmet need for novel therapies in the treatment of chronic pain. The currently available treatments may provide suboptimal efficacy and tolerability to certain patients. Digital therapeutics (DTx) is a new and rapidly evolving treatment paradigm, also for pain. We are exploring different solutions, such as this DTxP, for the future of pain care”, says Sammeli Liikkanen, Director of Digital Medicine at Orion Corporation.

“Cognitive Behavioral Therapy (CBT) is scientifically sound, effective and a recommended method to improve the self-management of chronic pain. For many suffering with difficult pain and disability, it is one option to reverse the decline in loss of function, and help people return to valued goals and activities. However, the access to qualified practitioners is very limited and getting smaller as the number of people with pain grows. DTx solutions operating within a CBT framework could bring new treatment options, potentially more powerful treatment options, to a larger population of patients”, says Christopher Eccleston, Professor of Pain Research at University of Bath.

Orion is looking for a partner to further develop and commercialise Orion’s digital therapeutics software solution for Chronic Pain.

Orion’s digital therapeutics software solution for Chronic Pain (DTxP)

Orion’s DTxP, aimed to be a software as medical device (SaMD), is built for virtual reality (VR) devices to provide an immersive gamified therapeutic treatment program for the chronic pain patients. The product contains behaviour change advice and instruction, presented as modules that can be tailored to the patients’ needs. The product is designed to be flexible and to be used as a part of multiple different treatment approaches. It also provides objective data to patients and treating healthcare professionals. As an example, gamified physical movements with proven safety targeted to encourage movement can lead one to overcome the fear of movement, and so increase activity. The software has been developed by Orion in close collaboration with external scientific advisor Christopher Eccleston from University of Bath, and technology partner Healthware Group, with support from Business Finland.

The VIRPI trial design

The VIRPI trial is a prospective, randomised, double-blind, 3-arm parallel group comparison of DTxP, passive control (a placebo “sham” running on VR specifically developed for this purpose) and an open standard care arm evaluating the safety and efficacy of DTxP in patients with chronic low back pain (CLBP). Inclusion criteria were low back pain for at least 3 months, average pain intensity of ≥4 over the past week on a 0–10 Numerical Rating Scale (NRS), Oswestry Disability Index (ODI) of ≥26%, and medium (34-41) or high (42-68) Tampa Scale for Kinesiophobia (TSK) score.

A total of 42 patients were randomised to receive DTxP (14), passive control (17) or standard care (11). Participants undertook DTxP or passive control for 15-60 minutes at a time, on 5 or more days per week up to the end-of-intervention (EOI). EOI was defined as the completion of 30 modules of DTxP or passive control, which took 6-8 weeks. Approximately 3 months after the EOI, information about pain status, disability, kinesiophobia, overall status and any adverse event (AE) were collected as follow-up data. Quality of life (QoL) was evaluated with the EQ-5D-5L questionnaire. The third group, randomly assigned to the standard care arm, visited the site for screening on Day 1 and 6-8 weeks after randomisation. After week 9 follow-up visit, the participants were re-randomised between DTxP and passive control for the next 6-8 weeks, followed by a 3-month follow-up period.

Contact person:

Sammeli Liikkanen, Director of Digital Medicine, Orion Corporation
tel. +358 50 966 7466
sammeli.liikkanen@orion.fi

IASP 2021 Virtual World Congress On Pain website: https://iaspvirtualcongress.evareg.com/

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
www.orion.fi

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's net sales in 2020 amounted to EUR 1,078 million and the company had about 3,300 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Subsea 7 S.A. - Seaway7 awarded contract offshore Poland28.3.2024 17:15:00 CET | Press release

Luxembourg – 28 March 2024 - Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award to Seaway7, part of the Subsea7 Group, of a sizeable¹ contract by PGE Polska Grupa Energetyczna and Ørsted for the transport and installation of the substations for the Baltica 2 wind farm, offshore Poland. Seaway7’s scope includes the transport and installation of four substations. Offshore activity is scheduled to take place in 2026 utilising both our heavy lift and heavy transportation vessels. Baltica 2 is a 50:50 joint venture between PGE Polska Grupa Energetyczna and Ørsted. The wind farm, with a capacity of around 1.5 GW, will be located in the Polish sector of the Baltic Sea around 40 kilometres from shore at its closest point. Maria Eidesvik, VP for Europe and US at Seaway7 said: “This is our second contract award in the emerging Polish market and we are pleased to be taking a role in developing offshore wind in this key location. With this project we also look forward to continu

Meltwater partners with leading digital agency Social Factor28.3.2024 17:00:00 CET | Press release

SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Meltwater, a leading global provider of media, social and consumer intelligence, today announces a new partnership with Social Factor, a global digital agency focusing on social CRM and strategy. With this partnership, Meltwater and Social Factor customers will be able to leverage the best of Meltwater’s social analytics and social media management solutions alongside Social Factor’s specialization in social media operations and community management. Social Factor helps enterprise-level clients turn digital chaos into human connection through content moderation, community management, analytical data, governance, training, and security. They have deep expertise working with innovative technology solutions to foster customer engagement on behalf of Fortune 500 companies and other large, global enterprises. The Meltwater social listening and social media management solutions help teams to stay on top of conversations about their company, i

International Petroleum Corp. Annual General Meeting to be held on May 8, 202428.3.2024 17:00:00 CET | Press release

International Petroleum Corporation (“IPC” or the “Corporation”) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that its Annual General Meeting (the “Meeting”) of holders of common shares (“Shareholders”) will be held at the offices of Blake, Cassels and Graydon LLP, Suite 3500, 855 - 2nd Street S.W., Calgary, Alberta, Canada T2P 4J8 on Wednesday, May 8, 2024 at 8:00 a.m. (Mountain time), for the following purposes: To receive the audited consolidated financial statements of the Corporation for the financial year ended December 31, 2023 and accompanying report of the auditor;To set the number of directors of the Corporation at eight;To elect the eight nominees of the Corporation standing for election as directors of the Corporation to hold office until the next annual meeting of Shareholders or until his or her successor is duly elected or appointed;To appoint PricewaterhouseCoopers SA, as the auditor of the Corporation, to hold office until the next annual meeting of Shareholder

SOFTSWISS Unveils South African iGaming Market Overview28.3.2024 16:52:00 CET | Press release

South Africa’s iGaming market is on a remarkable growth trajectory, set to reach a total revenue of approximately EUR 64.9 million by 2028. SOFTSWISS, a leading iGaming software provider with 15 years of experience, shares the South African market report. GZIRA, Malta, March 28, 2024 (GLOBE NEWSWIRE) -- In light of the recent acquisition of Turfsport, a leading South African provider of wagering solutions, the SOFTSWISS report offers first-hand practical experience. The piece explores peculiarities distinguishing South Africa, including provincial licensing, sports betting, and gaming preferences. Provincial Licensing Online gambling in South Africa is governed by nine provincial regulatory bodies which operate under the National Gambling Board’s framework. Each body is responsible for licensing various gambling activities, including online sports betting, in their provinces. Christian Neuberger, CEO at Turfsport, adds: “While national legislation continues prohibiting interactive gami

Chief People Officer, Amy Hanlon-Rodemich to leave Nokia28.3.2024 15:15:00 CET | Press release

Nokia Corporation Stock Exchange Release 28 March 2024 at 16:15 EET Chief People Officer, Amy Hanlon-Rodemich to leave Nokia Espoo, Finland – Nokia today announces that its Chief People Officer, Amy Hanlon-Rodemich, will leave the company and step down from its Group Leadership Team. A recruitment process will begin immediately for her successor and Amy will retain an advisory role during her notice period. Amy joined Nokia in 2022 and has been key to renewing the company’s people services and employee experience. “This has been a difficult decision for me to take. I’ve enjoyed my time at Nokia and am looking forward to the next chapter in my career. I wish everyone at Nokia continued success,” commented Amy. “I would like to thank Amy for her contributions to Nokia and leadership of the People organisation. I wish her all the best with her future endeavours,” said Pekka Lundmark, President and CEO of Nokia. Lorna Gibb, Vice President, Labor & Employment, will assume the role of interi

HiddenA line styled icon from Orion Icon Library.Eye